GLP-1 Receptor Agonists - The Truth Behind the Trend
Stanford University via YouTube
-
14
-
- Write review
AI Engineer - Learn how to integrate AI into software applications
Get 20% off all career paths from fullstack to AI
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore a comprehensive 59-minute lecture from Stanford University's Diabetes Wellness Group Monthly Webinar series where Clinical Pharmacist Michael Blyumin delves into the world of GLP-1 receptor agonists. Gain deep insights into FDA-approved medications like Exenatide, Liraglutide, and Semaglutide, understanding their dosing protocols, administration methods, and therapeutic benefits including blood sugar control, weight management, and cardiovascular health improvements. Master the fundamentals of diabetes pathophysiology, learn how GLP-1s regulate blood sugar levels, and understand the intricate mechanisms of GLP-1 receptor agonists. Examine practical considerations for diabetes management, potential risks, and the implications of discontinuing these medications. Delivered by a certified diabetes education specialist with extensive clinical experience at Stanford Health Care, access accompanying presentation materials and connect with Stanford's Diabetes Care Program for ongoing support and resources. Additional mindfulness and meditation resources are available through Stanford Health Library to support overall wellness during treatment.
Syllabus
GLP-1 Receptor Agonists: The Truth Behind the Trend
Taught by
Stanford Health Care